The ACCC annual survey to identify emerging trends across US cancer programs found costs of drugs and new treatment modalities as the largest threat to future cancer program growth.READ MORE
From December 9-12, the American Society of Hematology will be hosting its Annual Meeting and Exposition in Atlanta, Georgia. The meeting will provide an opportunity to review thousands of scientific abstracts highlighting updates in the hottest topics in hematology as well as to network with top minds in the field. READ MORE
To gain a better understanding of the newly available options for patients with this hematologic malignancy, Journal of Clinical Pathways spoke with Natalie S Callander, MD, professor of hematology/oncology at University of Wisconsin School of Medicine and Public Health (Madison, WI). READ MORE
The European Medicines Agency approved its first biosimilar product in 2006; the United States biosimilar market remains in its infancy. The United States must look to the European Union as biosimilar adoption continues to grow. READ MORE